8-K filing — Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Enters Exclusive Partnership With Henry Schein's Biohorizons To Distribute The Company's Allogeneic Growth Factor Technology Under The Prolifica Private Brand

The agreement establishes BioHorizons as the exclusive distributor of Xtant's allogeneic growth factor technology into the dental and oral-maxillofacial procedure markets in the United States and Canada, expanding

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release, Q2 earnings

Xtant Medical Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its fY26 sales guidance.

8-K filing — Xtant Medical Holdings, Inc. (XTNT)

Filed: 2026-08-11 AccNo: 0001493152-26-036979 Size: 381 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits